AUA -- Patients undergoing external-beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancy, according to a study from researchers in Canada, Italy and the United States presented today during the Annual Scientific Meeting of the American Urological Association (AUA) in Orlando. Researchers presented data to reporters during a special press conference on May 19, 2008 at 1:30 p.m.
